GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness

Stock Information for Genetic Technologies Ltd

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Genetic Technologies Ltd

Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
Genetic Technologies Announces $2 Million Registered Direct Offering
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
GeneType Clinicians' Adoption Growing - Sales up 5-Fold Year on Year
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
GTG to pilot GeneType in Breast Screen centers across the U.S.
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk"
Genetic Technologies' Digital Strategy Ignites Significant Traction in US Market

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.